Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 16/20 | 0.69 |
| ▸ | MTNR1B | P49286 | 12/20 | 0.69 |
| ▸ | HTR2C | P28335 | 11/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5227065 | 0.89 | MTNR1A (0.70) | MTNR1AMTNR1BHTR2C | |
| SCHEMBL5227741 | 0.88 | MTNR1A (0.59) | MTNR1AMTNR1BHTR2C | |
| SCHEMBL6076520 | 0.85 | MTNR1A (0.49) | MTNR1AMTNR1BHTR2C | |
| SCHEMBL5226600 | 0.84 | MTNR1A (0.65) | MTNR1AMTNR1BHTR2C | |
| SCHEMBL5226604 | 0.81 | MTNR1A (0.61) | MTNR1AMTNR1BHTR2C | |
| SCHEMBL5225086 | 0.80 | MTNR1A (0.57) | MTNR1AMTNR1BHTR2C | |
| SCHEMBL5225798 | 0.77 | MTNR1A (0.40) | MTNR1AMTNR1BHTR2C | |
| SCHEMBL5223857 | 0.75 | MTNR1A (0.72) | MTNR1AMTNR1BHTR2C | |
| SCHEMBL5228827 | 0.75 | MTNR1A (1.00) | MTNR1AMTNR1BHTR2C | |
| SCHEMBL5263981 | 0.73 | MTNR1A (0.57) | MTNR1AMTNR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6602903-B2 | Substituted O- and/or S heterocyclic compounds; powerful ligands for melatoninergic receptors. | LES LABORATORIES SERVIER (FR) | 2003-08-05 | — | — | US | claimed |
| EP-0998471-B1 | SUBSTITUTED HETEROCYCLIC COMPOUNDS, METHOD FOR PREPARING AND COMPOSITIONS CONTAINING SAME | SERVIER LAB (FR) | 2007-03-14 | — | — | EP | disclosed |
| US-6313160-B1 | FOR THERAPY AND PROPHYLAXIS OF MELATONINERGIC DISORDERS | ADIR ET COMPAGNIE (FR) | 2001-11-06 | — | — | US | disclosed |